| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA520530 | 4 | IC50 | = | 200 | uM | ALA2401501 | nM | Homo sapiens | |||
| 2. | ALA520530 | 4 | IC50 | = | 30 | uM | ALA2401499 | 4.52 | nM | Homo sapiens | ||
| 3. | ALA520530 | 4 | IC50 | > | 200 | uM | ALA2401500 | nM | ||||
| 4. | ALA520530 | 4 | Activity | 0 | ALA2401490 | Non-toxic | ||||||
| 5. | ALA520530 | 4 | Activity | 0 | ALA2401486 | Active | ||||||
| 6. | ALA520530 | 4 | Activity | 0 | ALA2401485 | Active | ||||||
| 7. | ALA520530 | 4 | Activity | 0 | ALA2401378 | Active | ||||||
| 8. | ALA520530 | 4 | Activity | 0 | ALA2401375 | Toxic | ||||||
| 9. | ALA520530 | 4 | Activity | = | 50 | % | ALA2401374 | % | Hepatitis B virus | |||
| 10. | ALA520530 | 4 | Activity | 0 | ALA2401502 | Active | ||||||
| 11. | ALA520530 | 4 | Activity | 0 | ALA2401488 | Non-toxic | ||||||
| 12. | ALA520530 | 4 | Activity | 0 | ALA2401487 | Non-toxic | ||||||
| 13. | ALA520530 | 4 | Activity | 0 | ALA2401489 | Dose-dependent effect | ||||||
| 14. | ALA520530 | 4 | IC80 | = | 207 | uM | ALA1021027 | uM | ||||
| 15. | ALA520530 | 4 | IC50 | = | 29.2 | uM | ALA1021027 | 4.54 | nM | |||
| 16. | ALA520530 | 4 | MIC | = | 0.195 | ug ml-1 | ALA998221 | ug.mL-1 | Cryptococcus neoformans | |||
| 17. | ALA520530 | 4 | IC50 | = | 0.045 | ug ml-1 | ALA998221 | ug.mL-1 | Cryptococcus neoformans | |||
| 18. | ALA520530 | 4 | MIC | = | 50 | ug ml-1 | ALA998220 | ug.mL-1 | Candida albicans | |||
| 19. | ALA520530 | 4 | IC50 | = | 7 | ug ml-1 | ALA998220 | ug.mL-1 | Candida albicans | |||
| 20. | ALA520530 | 4 | IC80 | = | 207 | uM | ALA992382 | uM |
The page will load shortly, Thanks for your patience!